Neurological manifestations related to VGKC levels
| Patient | Age | Sex | VGKC (pM) | Subtype | Cancer | Diagnosis |
|---|---|---|---|---|---|---|
| 1 | 64 | M | 5143 | LGI1 | No | LE |
| 2* | 64 | M | 3913 | LGI1 | No | LE |
| 3 | 74 | M | 3790 | LGI1 | Lip | LE |
| 4* | 68 | M | 2987 | LGI1 | Thyroid | LE |
| 5 | 74 | F | 1349 | LGI1 | No | LE |
| 6 | 54 | M | 1043 | LGI1 | No | LE |
| 7 | 69 | M | 827 | NA | No | MG, PNP |
| 8 | 64 | M | 748 | LGI1 | No | LE |
| 9 | 68 | M | 733 | LGI1 | No | LE |
| 10 | 66 | M | 576 | No | No | LE |
| 11 | 55 | M | 576 | No | No | LE |
| 12 | 54 | F | 555 | LGI1 | No | NMT |
| 13 | 19 | M | 209 | NA | No | CFS |
| 14 | 64 | F | 200 | No | No | TGA |
| 15 | 21 | M | 192 | No | No | Multiple sclerosis |
| 16* | 88 | F | 189 | No | Lung | Leukoaraiosis |
| 17 | 70 | F | 168 | No | Lymphoma | PNP |
| 18 | 60 | M | 163 | NA | No | PNP |
| 19 | 19 | M | 156 | No | No | Vasculitis |
| 20 | 20 | F | 152 | No | No | Headache |
| 21 | 53 | M | 140 | LGI1 | No | AIDP |
| 22 | 60 | M | 139 | No | No | MSA |
| 23* | 82 | M | 134 | No | Prostate | Met. plex. |
| 24 | 42 | M | 127 | No | No | Astrocytoma |
| 25* | 88 | M | 127 | No | Leukaemia | Cerebellar ataxia |
| 26 | 67 | M | 122 | No | No | PNP |
| 27 | 51 | F | 120 | No | No | Myelopathy |
| 28 | 33 | F | 117 | No | No | PNES |
| 29* | 83 | M | 116 | No | Lung | MG |
| 30 | 24 | F | 116 | No | No | Schizophrenia, Crohn's disease |
| 31 | 71 | F | 115 | No | No | RBD |
| 32 | 25 | F | 109 | No | No | MG |
*Patients dead within 2012.
AIDP, acute inflammatory demyelinating polyneuropathy; CFS, cramp fasciculation syndrome; LE, limbic encephalitis; LGI1, leucine-rich, glioma-inactivated 1 antigen; Met. plex., metastatic plexopathy; MG, myasthenia gravis; MSA, multiple system atrophy; NA, not available; NMT, neuromyotonia; PNES, psychogenic non-epileptic seizures; PNP, polyneuropathy; RBD, REM sleep behaviour disorder; TGA, transitory global amnesia; VGKC, voltage-gated potassium channels.